fda approves lung cancer treatment option
Published 5 months ago • 130 plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
5:00
biomarker status and lung cancer | morning blend
-
18:16
dellphi-301 - fda approval of tarlatamab in patients w/ prev treated small cell lung cancer (sclc)
-
3:01
new fda approved treatment for lung cancer (fcl july 2nd 2020)
-
0:37
amgen’s tarlatamab gets fda priority review for small cell lung cancer
-
0:46
fda approves capmatinib for advanced lung cancer
-
0:40
georgetown-led study leads to 1st fda-approved lung cancer drug combo in decades to improve survival
-
0:46
fda approves new drug to treat lung cancer
-
1:00:09
new options for lung cancer therapies
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
4:06
imdelltra: new fda-approved treatment for extensive-stage small cell lung cancer | 2024 update
-
1:38
more focus is needed on subtypes of lung cancer that do not have fda-approved targeted therapies
-
10:06
lung cancer: what are the newest treatment options available? - online interview
-
0:29
u.s. fda approves amgen’s targeted immunotherapy for adults w/extensive-stage small cell lung cancer
-
19:34
new fda-approved targeted therapy for alk positive lung cancers (nsclc) – excellent remission rates!
-
1:56
kansas mom now 7 years cancer free thanks to new fda approved clinical trial
-
19:14
aegean study - fda approval of durvalumab in resectable non-small cell lung cancer
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
3:24
fda approves expanded uses for immunotherapy
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer